SeedERP: Empowering High-Risk Industries with Smarter ERP
retailciooutlook

SeedERP: Empowering High-Risk Industries with Smarter ERP

Follow SeedERP on :

Andrew Goei, Co-Founder and Joseph Ricard, Co-Founder & CEO , SeedERPAndrew Goei, Co-Founder and Joseph Ricard, Co-Founder & CEO
As regulations across the U.S. and Canada change in favor of cannabis for recreational and medicinal use, the cannabidiol (CBD) industry is witnessing exponential growth. Despite the shift in the law, the fragmented CBD industry still lags in retailing as the market regulations and technology required to launch a business can be quite complex for an entrant to navigate. One of the biggest problems for CBD businesses is finding a retail technology solution that supports their high-risk business processes. Driven to turn this around by providing streamlined retail solutions for the cannabis and hemp industry, CloudPay Technologies established SeedERP, a smart retail platform for CBD retailers. The company enables clients to sign up with payment processors, build inventory, launch a website, and market their brand— all through a unified platform. SeedERP also pioneered the development of the world’s first smart, automated ID verification-based CBD vending machine.

“Our ERP platform is the first e-commerce solution designed specifically to support high-risk merchants such as CBD. We provide the industry peace of mind so that they can grow their business and process transactions without the fear of being shut down,” says Joseph Ricard, co-founder and CEO of SeedERP. By leveraging SeedERP, businesses can streamline order management, track inventory, manage customers and subscribers, and build online stores. The company has also integrated its payment gateway and processing solution with multiple sales channels such as e-commerce and point-of-sale systems. This facilitates clients to sell products across diverse locations and build a valuable distribution model to increase direct-to-consumer sales while creating a network of interactive billboards that improves brand awareness and drives traffic. SeedERP also features a website builder that has intuitive tools to design and launch a fully functional e-commerce store with an integrated payment gateway within hours.
Moreover, to improve payment processing, SeedERP has a built-in application process that enables clients to create merchant accounts seamlessly while offering low transaction rates. The platform can be leveraged by both the online as well as brick-and-mortar retailers to sell CBD products without disrupting their operations.


We provide the industry peace of mind so that they can grow their business and process transactions without the fear of being shut down


Businesses can further eliminate operational liability by utilizing the company’s smart CBD vending machines. SeedERP catalyzes adoption of a ‘plug and profit’ model with their vending machines that make it possible to sell CBD through isolated retail and payment solutions. When a consumer uses these machines, they are provided with detailed descriptions and a catalog of the products available in the climate-controlled environment of the machine. The buyer can also create new orders besides picking up their products. During this process, the machine takes a photo of the buyer, if necessary, which is stored along with the transaction data, while also allowing users to scan their IDs for age verification. “This enables us to capture valuable customer information and reduces the checkout time while protecting the buyer’s privacy,” explains Andrew Goei, co-founder of SeedERP.

Ricard cites a customer interaction, where a client faced hesitation from retail stores to sell CBD products as the store owners were concerned the products would create liabilities for their current payment processor. SeedERP saved the day with its payment gateway-integrated vending machines, which act as isolated retailers. This effectively eliminated the liability factor and strengthened the vendor-client relationship.

Going forward, SeedERP has exciting new plans to incorporate blockchain into the cannabis transaction model. Tracking transactions through an open ledger will not only help with compliance but also link over 2,500 cannabis strain data which can support medical research. “Even though we are focused on first resolving the problems at hand and stabilizing the industry, we are very keen innovators. We never want to be static in a dynamic market,” concludes Goei.

SeedERP News

LEUKOCARE Announces Appointment of Dr Andreas Seidl as New Chief Operating Officer and Member of the Executive Board

MUNICH, March 25, 2019 - Dr Andreas Seidl, hired as new Chief Operating Officer and member of the Executive Board, will be responsible for managing R&D operations as well as quality and regulatory, logistics and intellectual property of LEUKOCARE AG. He will assume his new role on April 1, 2019.

Munich-based biotechnology company LEUKOCARE announced today the appointment of Dr Andreas Seidl as new Chief Operating Officer and member of the Executive Board.

Dr Andreas Seidl joins LEUKOCARE with over 17 years' experience in analytical R&D from Sandoz/Novartis where he most recently was Head Global Analytical Characterization & Bioanalytics. During his career at Novartis he held different leadership positions in analytical & pharmaceutical development, analytical characterization and quality control of biopharmaceuticals. He coordinated the pioneering analytical and pharmaceutical development of the first complex biosimilar Binocrit® (INN: epoetin alfa) which gained market approval in the European Union by EMA/EC in 2007 and was since then working on the development of the next wave of biosimilars and innovative biopharmaceuticals such as mAbs and fusion proteins. Dr Andreas Seidl is a chemist by training and got his PhD from the University of Constance/Germany.

"I am delighted to welcome Andreas Seidl to LEUKOCARE. With his experience and proven track record in analytics and biological drug product development he is ideally qualified to help LEUKOCARE becoming the leading formulation developer. The entire LEUKOCARE team and I, personally, are very much looking forward to working with him," said Michael Scholl, CEO at LEUKOCARE.

"I am very happy to join LEUKOCARE at this exciting time in the company's development," commented Andreas Seidl. "I look forward to be an active part of LEUKOCARE's continued growth story towards a leading formulation development company," stated Dr Seidl.